| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.14 | 0.02 |